Press Releases

Just like their human owners, a dog's oral hygiene is tied directly to his overall health. According to the American Veterinary Dental Society, 80 percent of canines show symptoms of oral disease...

Perrigo Company plc (NYSE: PRGO; TASE) today announced that it will release financial results for its fourth quarter and fiscal year 2014 on Thursday, August 14, 2014 at approximately 8:00 a.m....

Perrigo Company (NYSE: PRGO;TASE) announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application for desoximetasone topical spray 0.25% and that...

Perrigo Company (NYSE: PRGO; TASE) today announced that it has received an AB therapeutic equivalent rating from the U.S. Food and Drug Administration (FDA) for its previously approved New Drug...

Perrigo Company (NYSE: PRGO; TASE) today announced that it was the first to receive final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for ibuprofen...

Perrigo Company plc (NYSE: PRGO; TASE) and its partner, Catalent, announced today that they have settled their first to file Hatch Waxman litigation with Teva with respect to a generic version of...

Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the Jefferies 2014 Global Healthcare Conference on Monday, June 2,...

Perrigo Company plc (NYSE: PRGO;TASE) announced that it has received final approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for azelastine...

Fiscal third quarter net sales increased 9% year-over-year to a record $1,004 million. Fiscal third quarter adjusted net income increased 31% to $176 million, or $1.31 per diluted share; GAAP net...

Perrigo Company plc (NYSE: PRGO;TASE) today announced that its Board of Directors declared a quarterly dividend of $0.105 per share, payable on June 17, 2014 to shareholders of record on May 30, 2014.